Mariana Lenharo Particles of SARS-CoV-2 (blue; artificially coloured) infect a cell.Credit: Steve Gschmeissner/SPL COVID-19 can inflict days of misery, even on people who do not develop serious illness. Now, trial data show that an antiviral called ensitrelvir shortens symptoms of mild to moderate COVID-19 by about a day — and is the first drug to make a...
Max Kozlov Molnupiravir offers the possibility of treating people in areas where monoclonal antibodies cannot be easily administered.Credit: Mariusz Burcz/Alamy Molnupiravir, one of two antiviral pills that have caused excitement in the past few months because preliminary clinical-trial results showed that they can significantly reduce hospitalizations and deaths from COVID-19, has yet to receive an emergency use...
Capsules of the experimental antiviral drug Molnupiravir. Pharmaceutical company Merck said Friday it will seek authorization in the US of its oral drug molnupiravir for COVID-19 after it was shown to reduce the chance newly infected patients were hospitalized by 50 percent. A simple pill to treat the coronavirus has been sought since the start...
